From: New GOLD classification: longitudinal data on group assignment
Variable | Patients |
---|---|
(N = 828) | |
Gender (M/F)* | 687 / 141 |
Age (y) | 67 (9) |
Pack-years | 56 (28) |
Active smoking* | 29% |
BMI (kg/m 2 ) | 28.1 (5.5) |
FEV 1 L | 1.65 (0.65) |
FEV 1 % | 56 (28) |
PaO 2 (mmHg) | 67.4 (9.6) |
FVC L | 3.130 (0.94) |
FVC% | 88 (19) |
FEV1/FVC | 53 (11) |
6MWD (m) | 438 (104) |
Dyspnea (mMRC)† | 1 (0-4) |
BODE index† | 4 (0-6) |
IC/TLC | 0.35 (0.10) |
K CO | 74 (24) |
Charlson index† | 1 (0-5) |
Exacerbations ≥2 per patient-years ‡ | 0.15 (0.01) |
Hospitalization ≥1 per patient-years ‡ | 0.12 (0.01) |
Inhaled anticholinergic* | 75% |
Inhaled β2-agonist* | 74% |
Inhaled corticosteroid* | 65% |
CAT† | 11 (2-27) |
CCQ† | 1,3 (0-3.7) |